Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries.

Yang LiuSimon R ProcterCarl A B PearsonAndrés Madriz MonteroSergio Torres-RuedaElias AsfawBenjamin UzochukwuTom DrakeEleanor BergrenRosalind M EggoFrancis RuizNicaise NdembiJustice NonvignonMark JitAnna Vassall

Published in: BMC medicine (2023)

Although ICERs increased significantly as vaccination programmes were delayed, programmes starting late in 2021 may still generate low ICERs and manageable affordability measures. Looking forward, lower vaccine purchasing costs and vaccines with improved efficacies can help increase the economic value of COVID-19 vaccination programmes.

Keyphrases

coronavirus disease
sars cov
healthcare
public health
mental health
randomized controlled trial
study protocol
health information
risk assessment